XML 29 R8.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Millions
Total
Parent
Common Stock
Treasury Stock
Additional Paid In Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Non-Controlling Interest
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Treasury stock at cost (in shares)       33,300,000        
Beginning Balance at Dec. 31, 2022     $ 42.4 $ (1,424.9) $ 792.2 $ 2,831.5 $ (211.6) $ 0.0
Beginning balance (in shares) at Dec. 31, 2022     68,600,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock, Shares     200,000          
Issuance of common stock     $ 0.1          
Share-based compensation effects         23.9      
Net Income $ 259.2         259.2    
Dividends declared (per share: $2.44 in 2025, $2.32 in 2024 and $2.20 in 2023)           81.2    
Other comprehensive income (loss) 44.0           44.0  
Stock Repurchased During Period, Value       2.6        
Less: Comprehensive Loss Attributable to Non-Controlling Interest 0.0              
Ending Balance at Dec. 31, 2023 2,273.0 $ 2,273.0 $ 42.5 $ (1,427.5) 816.1 3,009.5 (167.6) 0.0
Ending balance (in shares) at Dec. 31, 2023     68,800,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock repurchases (2.6)              
GABX equity contribution from non-controlling interest 0.0              
Treasury stock at cost (in shares)       33,300,000        
Issuance of common stock, Shares     300,000          
Issuance of common stock     $ 0.2          
Stock repurchases (in shares)       200,000        
Share-based compensation effects         31.0      
Net Income 284.2         284.2    
Dividends declared (per share: $2.44 in 2025, $2.32 in 2024 and $2.20 in 2023)           85.6    
Other comprehensive income (loss) $ (42.0)           (42.0)  
Balance at end of period, Common Stock, Shares at Dec. 31, 2024 69,075,329              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock Repurchased During Period, Value       $ 21.9        
Less: Comprehensive Loss Attributable to Non-Controlling Interest $ 0.0              
Ending Balance at Dec. 31, 2024 $ 2,438.9 2,438.9 $ 42.7 $ (1,449.4) 847.1 3,208.1 (209.6) 0.0
Ending balance (in shares) at Dec. 31, 2024 35,575,691   69,100,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock repurchases $ (21.9)              
GABX equity contribution from non-controlling interest $ 0.0              
Treasury stock at cost (in shares) 33,499,638     33,500,000        
Issuance of common stock, Shares     200,000          
Issuance of common stock     $ 0.2          
Stock repurchases (in shares)       400,000        
Share-based compensation effects         28.3      
Net Income $ 333.3         333.3    
Dividends declared (per share: $2.44 in 2025, $2.32 in 2024 and $2.20 in 2023)           90.2    
Other comprehensive income (loss) $ 90.6           105.0  
Balance at end of period, Common Stock, Shares at Dec. 31, 2025 69,316,358              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Less: Comprehensive Loss Attributable to Non-Controlling Interest $ (14.4)           14.4 (14.4)
Ending Balance at Dec. 31, 2025 $ 3,635.1 $ 2,750.5 $ 42.9 $ (1,514.4) $ 875.4 $ 3,451.2 $ (104.6) $ 884.6
Ending balance (in shares) at Dec. 31, 2025 35,400,021   69,300,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock repurchases $ (65.0)              
GABX equity contribution from non-controlling interest $ 899.0              
Treasury stock at cost (in shares) 33,916,337     33,900,000